Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Cirrhosis

Free Subscription 20.07.2026 4 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 1 Dig Dis 1 Dig Dis Sci 5 Hepatology 4 J Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. WANG X, Shen J, Guo J, Dong X, et al
   Inflammatory mediators are predictors of clinical outcomes in cirrhotic patients with non-acute decompensation.
   BMC Gastroenterol. 2026 Jul 17. doi: 10.1186/s12876-026-05105.
   PubMed         Abstract available
   
   
2. KRATZER W, Binzberger A, Kauschke SG, Dolze F, et al
   Point shear wave elastography for non-invasive detection of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: a prospective histologically validated study.
   BMC Gastroenterol. 2026;26:451.
   PubMed         Abstract available
   
   
3. JALLAD H, Khaled A, Qabaja H, Qabaja YA, et al
   Masked polycythemia vera presenting as non-cirrhotic portal hypertension with isolated gastric varices: a case report.
   BMC Gastroenterol. 2026 Jul 13. doi: 10.1186/s12876-026-05111.
   PubMed         Abstract available
   
   
4. MOUSA N, Elmetwalli A, Abdelsalam M, Wahba M, et al
   Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study.
   BMC Gastroenterol. 2026;26:439.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

5. BADWEI N, El-Folly RF, Abdu Hemdan HA, Mohamed Wassif GO, et al
   Delayed Mortality After Successful Hemostasis in Cirrhotic Upper Gastrointestinal Bleeding: A Prospective Observational Study.
   Clin Res Hepatol Gastroenterol. 2026 Jul 14:102886.
   PubMed        
   
   

   
   Dig Dis

6. CHIU YC, Tsai HJ, Chen CC, Lin YC, et al
   Predictors of Incident High-Risk Varices in Patients with Hepatitis B-related Cirrhosis Receiving Nucleos(t)ide Analogue Therapy.
   Dig Dis. 2026 Jul 16:1-20. doi: 10.1159/000553519.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

7. WILLIAMS EE, Lammert C, Vuppalanchi R
   Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.
   Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-026-09672.
   PubMed         Abstract available
   
   

   
   Hepatology

8. ZHOU XD, Chen QF, Fan QY, Kim SU, et al
   Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD.
   Hepatology. 2026;84:529-541.
   PubMed         Abstract available
   
   
9. CHOI J, Xu J, Nguyen VH, Przybyszewski E, et al
   Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation study.
   Hepatology. 2026 Feb 2. doi: 10.1097/HEP.0000000000001701.
   PubMed         Abstract available
   
   
10. SCHRADER C, Fromme M, Ellis P, Payance A, et al
    Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.
    Hepatology. 2026;84:542-558.
    PubMed         Abstract available
    
    
11. KARVELLAS CJ, Bajaj JS, Kamath PS, Napolitano L, et al
    Erratum: AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.
    Hepatology. 2026;84:E50.
    PubMed        
    
    
12. PREMKUMAR M, Sandhu A, Sharma P, Nain J, et al
    Recompensation of decompensated cirrhosis in a spectrum of metabolic-dysfunction-related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors.
    Hepatology. 2026 Jul 17. doi: 10.1097/HEP.0000000000001822.
    PubMed         Abstract available
    
    

    
    J Hepatol

13. INCICCO S, Patidar KR, Juanola A, Ma AT, et al
    Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.
    J Hepatol. 2026 Jul 15:S0168-8278(26)02717-0. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
14. HERNANDEZ-GEA V, Paradis V, Guindi M, Alves VAF, et al
    A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.
    J Hepatol. 2026;85:383-394.
    PubMed         Abstract available
    
    
15. LI S, Tong G, Xue M, Shen L, et al
    Activated hepatic stellate cells maintain liver bile acid homeostasis through paracrine FGF10/FGFR2 signaling.
    J Hepatol. 2026 Mar 26:S0168-8278(26)00149-2. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
16. SCHATTENBERG JM, Bedossa P, Guy CD, Taub R, et al
    Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial.
    J Hepatol. 2026;85:202-211.
    PubMed         Abstract available
    
    

    
    PLoS One

17. YUEN MF, Wastlund D, Lin TTY, Zheng Q, et al
    Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong.
    PLoS One. 2026;21:e0353882.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum